Sensor-Kinesis – Advanced Biosensor Technology: Patent Filing Press Release

Sensor-Kinesis Reveals New Carbon Nanotube BioFET for Analysis of Biomarkers

LOS ANGELES – May 12, 2015 – Sensor-Kinesis Corporation (SKC) announced the filing of a U.S. patent application entitled “Carbon Nanotube BioFET with a Local Amplifier in a System Array for Analysis of Biomarkers and Method of Analysis of Same”. The announcement was made in conjunction with SKC’s parent company, Pharmaco-Kinesis Corporation. Read more

Sensor-Kinesis – Advanced Biosensor Technology: SBIR Grant Press Release

Department of Defense Awards Grant to Develop Biosensor for Early Detection of Acute Organ Injury

LOS ANGELES, CALIFORNIA, May 31, 2014 – Sensor-Kinesis Corporation (SKC) announced that its parent company Pharmaco-Kinesis Corporation (PKC) has been awarded a grant by the U.S. Department of Defense (DoD) for development of its “Carbon Nanotube Based Biosensor for Organ Injury Detection”. SKC’s biosensor technology was competitively selected for the Phase I grant award, totaling $150,000, under the Small Business Innovation Research (SBIR) program of the DoD Defense Health Program (DHP). Read More

Frost & Sullivan Acknowledges That SKC’s Biosensors Are Expected To Become The New Industry Standard In Pathogen Testing

MOUNTAIN VIEW, CALIFORNIA, February 13, 2013 – Based on its recent analysis of the global biosensors market, Frost & Sullivan recognized Sensor-Kinesis’ (SKC) parent company  Pharmaco-Kinesis Corporation (PKC) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company has set a new standard in the biosensors market with its innovative, highly sensitive biosensor. Read more